Researchers from Singapore-MIT Alliance for Research and Technology (SMART), MIT’s research enterprise in Singapore, have discovered a new anti-phage defense mechanism found in some bacteria, which use previously unknown features to protect their DNA. The groundbreaking discovery enables scientists to overcome existing challenges in bacterial resistance to antibiotics. The growing antimicrobial resistance is a major concern for the global health community, and phage therapy is an important pillar in combating bacterial infections.
Bacteriophages, an effective alternative to fight bacteria that are resistant to commonly used antibiotics, work by injecting their own DNA into the bacteria, where it can replicate to the point that it destroys the bacteria. In a paper published in Nature Microbiology, the research team describes a new defense system found in many bacteria that work in unique ways to protect themselves against bacteriophages.
Led by Professor Lianrong Wang at Wuhan University, the paper was jointly written by a group of scientists at SMART’s Antimicrobial Resistance (AMR) Interdisciplinary Research Group (IRG), Shanghai Jiao Tong University, and Tsinghua University. SMART’s AMR IRG is a translational research and entrepreneurship program that aims to solve the growing threat of resistance to antimicrobial drugs.
“We previously discovered a new type of defense mechanism that bacteria use against phages, where sulfur is inserted into the DNA backbone as a phosphorothioate modification on each strand of the DNA,” says Professor Peter C. Dedon, co-author of the paper and lead principal investigator at SMART AMR. “If the attacking phage DNA didn’t have the modifications, host enzymes would chop the DNA into pieces to destroy it. This restriction-modification mechanism is like a bacterial immune system to protect against invaders.”
“What the team discovered now is an entirely new and different mechanism in which phosphorothioates are located on only one strand of DNA at very high frequency. The host defense enzymes then nick one strand of the invader DNA to stop the virus from making copies of itself. Like a surgeon’s knife compared to a meat cleaver.”
The newly identified SspABCD-SspE PT system is unique from the previously known PT modification system, which uses multiple proteins and enzymes to attack phage DNA by chopping it into pieces. The discovery will help researchers understand how to tackle the ever-growing arsenal of bacterial defenses against phages and can have huge implications for phage therapy.
“We keep pushing to discover DNA modification systems in phages as well as in bacteria. There are likely to be many more waiting to be found. We’re finding some bizarre new ones that can be exploited to engineer phages to thwart bacterial defenses in common pathogens,” adds Dedon, who is also a professor at MIT who helped create the Institute's Department of Biological Engineering.
AMR IRG is a translational research and entrepreneurship program that tackles the growing threat of antimicrobial resistance. By leveraging talent and convergent technologies across Singapore and MIT, they aim to tackle AMR head-on by developing multiple innovative and disruptive approaches to identify, respond to, and treat drug-resistant microbial infections. Through strong scientific and clinical collaborations, their goal is to provide transformative, holistic solutions for Singapore and the world.
SMART, which serves as an intellectual and innovation hub for research interactions between MIT and Singapore, was established by MIT in partnership with the National Research Foundation of Singapore (NRF) in 2007. SMART is the first entity in the Campus for Research Excellence and Technological Enterprise (CREATE) developed by NRF. It currently comprises an Innovation Center and five interdisciplinary research groups: Antimicrobial Resistance, Critical Analytics for Manufacturing Personalized-Medicine, Disruptive and Sustainable Technologies for Agricultural Precision, Future Urban Mobility, and Low Energy Electronic Systems. SMART research is funded by the National Research Foundation Singapore under the CREATE program.
